At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination: A Prospective, Randomized, Double-blind, Placebo-Controlled Trial (Trial 2)
In Brief
A clinical study evaluating 1 week placebo(Week 1), 1 week of probiotics(Week 1), and 4 other interventions for SARS-CoV-2. Completed, enrolled 44 participants across 2 sites.
Detailed Summary
Preliminarily explore the effect of oral probiotics in SARS-CoV-2 serum neutralizing antibody titer level and T cell response level (spot formation cell counting). Provide a reference for determining the appropriate oral regimen. Provide necessary parameters for estimating the sample size of confirmatory clinical trial.
Study Details
Timeline
Interventions
1 week of consecutively consuming oral placebo (1 time/day)
1 week of consecutively consuming oral probiotics (1 time/day)
1 week of consecutively consuming oral placebo (1 time/day)
1 week of consecutively consuming oral probiotics (1 time/day)
1 week of consecutively consuming oral placebo (1 time/day)
1 week of consecutively consuming oral probiotics (1 time/day)